This site is intended for healthcare professionals

Phase III VOYAGER PAD study of Xarelto meets primary endpoints in symptomatic peripheral artery disease.- Janssen

Read time: 1 mins
Published:29th Mar 2020
Condition: Peripheral Artery Disease
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest